secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2022-08-16T23:59:59+00:00
Accession:  0001477932-22-006194
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx appoints Mickie Henshall as independent director effective Aug 15, 2022
--------------------------------------------------------------------------------

- Board expanded to nine members; Henshall fills new vacancy and serves on Compensation and Nominations & Governance Committees.
- Henshall receives 15,000 RSUs vesting in two equal installments at 12 and 24 months; cash compensation waived.
- Henshall brings over 20 years of IVD and life sciences marketing experience; currently CMO of REALM IDx, Inc.
- No family relationships or related-party transactions disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793222006194/0001477932-22-006194-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793222006194/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-22-006194

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer